Screening & Diagnosis Solution

Time is precious when it comes to effective screening, detection and diagnosis of breast cancer. We strive to improve efficiencies at every step, ensuring more women have more time in better health.

Healthcare professional pointing to breast scan image on monitor

Advance Early Detection & Diagnostic Accuracy

Our clinically proven, integrated breast imaging and diagnostic solutions can optimise your clinical pathway while enhancing a woman’s breast imaging experience.

Cutting-Edge Imaging

Optimal cancer detection starts with the highest quality imaging. Integrate the EUREF-approved1 Hologic mammography technologies into your clinical pathway to maximise efficiency in your imaging workflow.

Confident Cancer Detection

The clinically proven tomosynthesis and contrast enhanced imaging technologies, plus future-proofed AI powered solutions at the point of care, help you make the best clinical decisions while accelerating reading time and improving operational efficiency.

Compassionate Interventional Solutions

Bringing high quality imaging and intervention together helps you deliver more compassionate and effective solutions. Choose from stereotactic, ultrasound and MRI compatible biopsy markers. Tailor biopsy treatment options in prone or upright mode to help improve the patient experience.

Diagnostic & Data Efficiency

Powerful high-resolution imaging solutions require integrated, streamlined and breast-specific workflows. Our diagnostic workstations, scalable archiving and versatile image routing solutions can optimise reading workflow, minimise network burden and grow with your clinical needs.

Decades of Continuous Innovation

Our pioneering technology supports best-in-class detection and diagnostics,* delivered with speed and accuracy.1

3.7s

Scan Time, the industry’s fastest tomosynthesis scan² on the 3Dimensions™ Digital Mammography System**

1h

Daily saving in image interpretation time3,4 with 3DQuorum™ Imaging Technology

70 Micron

sharper images with Clarity HDTM High Resolution Tomosynthesis5

Browse our Flagship Range

Visit Our Virtual Hospital

Browse our portfolio of Breast Health solutions in 3D. See how you can unlock the advantage of time across the entire Breast Continuum of Care. 

Woman enquiring receptionist at the Breast Imaging Suite

    * The only system to have received EUREF certification for both 2D and 3D.
    ** Compared to other standard models.
    † When using 3D plus 2D exam

    1. Results EUREF type test. Available at: https://www.euref.org/type-test-equipment/euref-type-test-results (accessed November 2022)
    2. Rocha Garcia, A.M., Mera Fernandez, D. Breast tomosynthesis: State of the art. Radiologia. 2019;61(4):274-285. 
    3. Hologic data on file: CSR-00130 Rev 001
    4. Data on File: Clinical Study Report CSR-00116, Rev 004
    5. Compared to other standard models. Rocha Garcia, A.M., Mera Fernandez, D. Breast tomosynthesis: State of the art. Radiologia. 2019;61(4):274-285
    6. Friedewald SM., Rafferty EA., Rose SL., et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.
    7. Hologic data on file:  MAN-06153 Rev 002. 3DQuorum Physician’s Labeling
    8. Hologic data on file: MAN-06029-002 Rev 004 3D Quorum User Guide
    9. Hologic data on file: TFS-00002 Rev 003.
    10. Hologic data on File: DHM-09325 Rev 003.
    11. Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Non-dense Breasts. JAMA. 2016 Apr 26;315(16):1784-6.
    12. Dense breast higher risk factor. Available at: https://www.cancer.gov/types/breast/breast-changes/dense-breasts#:~:text=Dense%20breasts%20are%20not%20considered,than%20women%20with%20fatty%20breasts. (Accessed Nov 2022)
    13. ACR BI-RADS Atlas 5th Edition. 2013. Available at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-Rads (Accessed Nov 2022).
    14. Tozaki M, Fukuma E. Pattern classification of ShearWave™ Elastography images for differential diagnosis between benign and malignant solid breast masses. Acta Radiol. 2011;52(10):1069-1075. doi: 10.1258/ar.2011.110276.
    15. Rose SL, Tidwell AL., Bujnoch LJ., et al. Implementation of breast tomosynthesis in a routine screening practice: an observational study. AJR AmJ Roentgenol. 2013;200(6):1401-1408
    16. Haas BM., Kalra V., Geisel J., et al. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology 2013;269:694-700.

     

    Related Portfolio & Solutions

    Healthcare professional pointing to screen on medical device
    Portfolio

    Breast Health Continuum of Care

    Time is precious when it comes to effective detection, diagnosis and treatment of breast cancer. We strive to save you time at every step along the Breast Health Continuum of Care ensuring more women have more time in better health.

    Solution

    Risk Assessment

    Solution

    Breast Biopsy

    Solution

    Localisation & Marking

    Solution

    Excision & Filling

    Solution

    Specimen Radiography

    Solution

    Specimen Pathology

    Solution

    Metabolic Health

    2797

    Hologic BV, DA Vincilaan 5, 1930 Zaventem, Belgium

    Notified Body number wherever applicable
    EC Representative Information wherever applicable